CV

Professor David Gloriam is a leading expert in G protein-coupled receptors (GPCRs), recognised as a top 1% most cited researcher globally. Raising over DKK 100 million in research funding and leads one of the field’s most widely used online database platforms, GPCRdb, which supports over 50,000 users annually across academia and industry. He has developed computational tools used by pharmaceutical companies and GPCRgraphs, a next-generation virtual screening platform targeting previously inaccessible GPCRs. In addition to his academic achievements, David has an increasing involvement in innovation, including as Senior Scientific Expert at Kvantify, collaborator on commercially oriented drug design programs, entrepreneurship training an applicant on several innovation projects.

POSITIONS
2022- Senior scientific expert, Kvantify A/S (Life science scale-up, 5h/w)
2019- Professor, 2011-18 Associate Professor & 2008-11 Postdoc at the Department of Design and Pharmacology, University of Copenhagen
2007-08 Postdoc, GlaxoSmithKline, Harlow, UK
2006-08 Postdoc, EMBL-European Bioinformatics Institute (EBI)

DEGREES
2006 Ph.D. in Medicine, Uppsala University
2003 M.Sc. in Pharmaceutical Sciences, Uppsala University

SCIENTIFIC HONORS & AWARDS
2022- Clarivate highly cited researcher (top 1% in the cross-field category)
2023 IUPHAR Analytical Pharmacology Award (awarded every 4^th year at World Congress)
2013/22 Best/second best structure model in global competition, ‘GPCR Dock’ (5-HT_1B/NPY₁)
2021 Lars Arge prize for big data from the Royal Danish Academy of Sciences and Letters
2019 Personal calling as full Professor – given rarely to excellent researchers.
2019 UCPH Forward Talent Program (only 24 exclusive seats for the entire University)
2014- Member (by invitation) of the International Union of Pharmacology Nomenclature Committee
This issues authoritative global guidelines on receptor nomenclature and drug classification.

BIBLIOMETRICS
For publications, h-index and citations, please see:
Google Scholar profile
Scopus publication list

FUND RAISING
DKK 100 M as main applicant, e.g.:
2023 Novo Nordisk Foundation Research Infrastructure (DKK 12M)
2022 Lundbeck Foundation Collaborative Project (DKK 35 M)
2018/9 Ascending Investigator grants from Novo Nordisk & Lundbeck Foundations (DKK 10/5 M)
2014 ERC Starting grant and Lundbeck Foundation Fellow (DKK 11.2/10 M)

INNOVATION
2025 4-day start-up course “REBBLS” taught by experts in entrepreneurship, patenting and regulatory affairs
2025 20+ start-up mentorship and strategy meetings and applied for IFD Innoexplorer (pending)
2023- Senior Scientific Expert at the Danish startup Kvantify
2014- Developed innovative data-driven tools for drug discovery & experiment design in GPCRdb (e.g., publ. 3-4), which has several patents citations and has been setup internally within several pharma companies.
2015/17 Developed a ligand-based virtual screening method and published proof-of-concept (publications 6-7)

LEADERSHIP
International leadership
2014- Head of GPCRdb.org – the GPCR field’s major database with >50,000 users/year (publ. 3-4)
2022 Led global community guidelines for biased signaling towards safer drugs. Published via the authoritative Nomenclature Committee of the International Union of Pharmacology (publication 5).
2019-20, 2014-17 Management Committee member, EU COST Actions ‘ERNEST’ & ‘GLISTEN’

Institutional leadership
Year    Level   Role     Committee
2020-, Faculty, Member, Center for Health Data Science (heads.ku.dk) steering group
2019-23, Dept., Head, GPCR research cluster (one of seven research clusters)
2019-2023, Dept., Head, Research leadership forum
2018-20, Faculty, Member, Data Science Lab
2018-22, Dept., Head, Pharmaceutical Data Science unit
2018, Dept., Member, Strategy and reorganization committees
2017,2023, Dept., Member, Career and recruitment committee

Formal leadership training
2022 EMBO Solutions – Laboratory Leadership for Group Leaders (3 days)
2019 Talent Program ‘UPCH Forward’ (10 mo., led by previous leaders of Centers of Excellence)
2016- Mentoring by three leaders of centers in drug discovery, structural biology or data science
2016 Leadership coaching by Mobilize Strategy Consulting
2012 Diploma in Research Management, CBS Executive (3*3 days + 2 books)

CONFERENCE TALKS
51 invited talks at international conferences e.g.:
2024 GPCR-Targeted Drug Discovery Summit Europe, UK
2024 Analytical Pharmacology Lecture, World Congress of Basic & Clinical Pharmacology, UK
2023 Gordon Research Conference on Molecular Pharmacology, Switzerland

TEACHING AND RESEARCH EDUCATION
Teaching
2026 (prepared in 2025)- Course leader for new PhD course on data science in drug discovery
2008- Teaching typically ~100h/year across the MSc, PhD, and industry professional levels.
Current courses: Medicinal and biostructural chemistry (MSc), Receptor structure and function (PhD), Molecular pharmacology (PhD) and AI in drug discovery (industry professionals)

Supervision (as main PI at UPCH)
- Current/all: 0/4 Assis Prof, 3/14 Postdocs, 3/13 PhDs, 1/4 research assistants, 1/30 M.Sc. thesis projects and 3/5 AC-TAPs (technicians)
- Former members attain attractive industry or academic positions e.g., two tenured Assoc Prof.

Formal pedagogic training
2012 PhD supervision course (2 days)
2008 University pedagogy course “Higher education teaching” (250 h)